Home / Health / Bhat's GLP-1 Experiment: No Appetite Suppression
Bhat's GLP-1 Experiment: No Appetite Suppression
25 Feb
Summary
- Tanmay Bhat is experimenting with GLP-1 drugs for weight loss.
- He found a gene variant linked to weakened satiety signalling.
- Bhat previously lost 75 kgs without such medications.
Comedian Tanmay Bhat, known for his involvement with AIB and a successful YouTuber, is currently experimenting with GLP-1 drugs, which are often prescribed as appetite suppressants to aid weight loss. Bhat revealed on the social platform X that since beginning the regimen, he has observed "zero appetite suppression." This lack of effect prompted him to investigate further, leading to the discovery of a specific gene variant linked to weakened satiety signalling.
Responding to public commentary, Bhat clarified that his current exploration with GLP-1s is driven by an interest in new health technologies. He highlighted his history of significant weight loss, having previously shed over 75 kilograms without the use of such drugs, while maintaining a consistent workout routine and diet, supported by regular blood work and expert guidance.
Other public figures have also shared their experiences with similar medications. Comedian Aishwarya Mohanraj recently discussed her use of Mounjaro, detailing mental health challenges and a derailed fitness journey due to injury. The medical community, including Dr. AG Unnikrishnan, advises on the cautious use of GLP-1 drugs, stressing their role as chronic condition management alongside diet and exercise, with dosage adjustments being case-specific.
